Insights from the ADVOCATE Study: Respiratory Tract Involvement in Patients with ANCA-Associated Vasculitis in a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Avacopan
C93. CLINICAL TRIALS IN CHRONIC LUNG DISEASE | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A4780-A4780
10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4780